Simple blood test may predict deadly clots in cancer patients

NCT ID NCT06051214

Recruiting now Knowledge-focused Sponsor: Institut Cancerologie de l'Ouest Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a monthly blood test can predict dangerous blood clots in people with certain cancers (lung, pancreatic, stomach, or brain). Cancer patients are at high risk for clots, which can be deadly. Researchers will follow 200 participants for 12 months, taking blood samples each month to measure how their blood clots. The goal is to develop a simple test that could help doctors prevent clots before they happen.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood test that helps doctors identify which cancer patients are at highest risk for dangerous blood clots, allowing earlier prevention.
What could go wrong: This is an observational study, not a treatment trial. It is still recruiting and results may not lead to a widely used test. The blood test may not reliably predict clots in all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma gastric cancer glioblastoma lung cancer malignant pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID CARCINOMA

Contacts and locations

Locations

Institut de Cancerologie de L'Ouest
RECRUITING

Saint-Herblain, 44805, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.